news

 

Indian law firm J. Sagar Associates has advised Edelweiss Alternatives’ Rental Yield Plus Fund on its acquisition of Bengaluru-based MMTP Projects for 15 billion rupees ($179 million).

MMTP and the sellers, MFAR Group, were represented by Shardul Amarchand Mangaldas & Co.

MMTP owns and operates 1.1 million square feet of gross leasable area within the larger Manyata Tech Park – a prominent technology park in Bengaluru housing multiple office spaces for companies from various sectors.

Edelweiss Alternatives, the alternative asset arm of the Edelweiss Group, set up its Rental Yield Plus Fund last year to seek out and invest in commercial office properties in six Indian cities.

“The acquisition of MMTP is in line with Edelweiss’ larger strategy of aggregating high-quality Grade A/A+ office assets into a larger portfolio of commercial office assets across pivotal office micro-markets in key cities,” JSA said in a statement.

The JSA team was led by joint managing partner Vivek Chandy, and included partner Ajay Prasad and senior associate Soham Roy. Partners Karthik BM (real estate), Megha Arora (power and regulatory), Anjana Potti (banking and finance) and Preetha S (due diligence) assisted on the deal.

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

CAM, WFW act on $185 mln Adani Ports acquisition

by Nimitt Dixit |

Cyril Amarchand Mangaldas advised its longstanding client Adani on Adani Ports and Special Economic Zone’s acquisition of 80 percent stake in Astro Offshore, an offshore support vessel operator. Watson Farley & Williams advised the selling shareholders of Astro Offshore.

Anagram adds M&A and PE partner from IndusLaw

by Nimitt Dixit |

M&A-focused Anagram Partners has become the latest to turn to IndusLaw to expand its offerings with the addition of M&A and private equity-focused partner Faraz Khan in Mumbai.

Trilegal, Latham, Quillon act on Platinum Equity’s India PE debut

by Nimitt Dixit |

Trilegal and Latham & Watkins have advised U.S.-based buyout fund Platinum Equity on its debut private equity deal in India, in the form of the acquisition of a majority stake in Inventia Healthcare, a Mumbai-based pharmaceutical company, at a valuation of $300 million.